These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 21499297
41. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, Yang Y, Zhang Y, Jiang J. Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765 [Abstract] [Full Text] [Related]
42. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts. Ge C, Zeng B, Li R, Li Z, Fu Q, Wang W, Wang Z, Dong S, Lai Z, Wang Y, Xue Y, Guo J, Di T, Song X. Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210 [Abstract] [Full Text] [Related]
43. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling. Gan X, Liu Z, Tong B, Zhou J. Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393 [Abstract] [Full Text] [Related]
44. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location. Wang G, Guo C, Zhao H, Pan Z, Zhu F, Zhang L, Wang Q. BMC Cancer; 2018 Mar 06; 18(1):260. PubMed ID: 29510688 [Abstract] [Full Text] [Related]
45. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling. Huang RS, Zheng YL, Zhao J, Chun X. Biomed Pharmacother; 2018 Feb 06; 98():538-544. PubMed ID: 29287202 [Abstract] [Full Text] [Related]
46. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. Cai F, Zhu Q, Miao Y, Shen S, Su X, Shi Y. J Cancer Res Clin Oncol; 2017 Jan 06; 143(1):59-69. PubMed ID: 27629878 [Abstract] [Full Text] [Related]
47. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. Cao W, Ribeiro Rde O, Liu D, Saintigny P, Xia R, Xue Y, Lin R, Mao L, Ren H. PLoS One; 2012 Jan 06; 7(12):e52984. PubMed ID: 23300840 [Abstract] [Full Text] [Related]
48. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC. Yang D, Wang JJ, Li JS, Xu QY. Oncol Res; 2018 May 07; 26(4):519-528. PubMed ID: 28734041 [Abstract] [Full Text] [Related]
49. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP. J Biol Chem; 2001 Dec 14; 276(50):47709-14. PubMed ID: 11598125 [Abstract] [Full Text] [Related]
50. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer. Nam AR, Kim JW, Park JE, Bang JH, Jin MH, Oh DY, Bang YJ. Cancer Res Treat; 2019 Jul 14; 51(3):886-900. PubMed ID: 30282449 [Abstract] [Full Text] [Related]
51. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4. Qin Y, Zhou X, Huang C, Li L, Liu H, Liang N, Chen Y, Ma D, Han Z, Xu X, He J, Li S. Gene; 2018 Oct 30; 675():278-284. PubMed ID: 29935356 [Abstract] [Full Text] [Related]
52. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A. Lu J, Zhou L, Wu B, Duan Y, Sun Y, Gu L, Xu D, Du C. Exp Cell Res; 2020 Feb 01; 387(1):111752. PubMed ID: 31805277 [Abstract] [Full Text] [Related]
53. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, Gaofeng L, Xin S. J Hematol Oncol; 2015 Oct 26; 8():120. PubMed ID: 26503334 [Abstract] [Full Text] [Related]
54. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway. Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q. J Cell Biochem; 2014 Jan 26; 115(1):81-92. PubMed ID: 23904219 [Abstract] [Full Text] [Related]
55. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Lu YJ, Liu RY, Hu K, Wang Y. Tumour Biol; 2016 Sep 26; 37(9):12685-12695. PubMed ID: 27448300 [Abstract] [Full Text] [Related]
56. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo MZ, Engles J, Yochem R, Ratovitski E, Sidransky D, Jen J. Oncogene; 2002 May 02; 21(19):3003-10. PubMed ID: 12082530 [Abstract] [Full Text] [Related]
57. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W, Sun M, Zang C, Ma P, He J, Zhang M, Huang Z, Ding Y, Shu Y. Cell Death Dis; 2016 May 19; 7(5):e2225. PubMed ID: 27195672 [Abstract] [Full Text] [Related]
58. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42. Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, Chen M. Tumour Biol; 2015 Mar 19; 36(3):1903-11. PubMed ID: 25432132 [Abstract] [Full Text] [Related]
59. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells. Su Z, Yin J, Zhao L, Li R, Liang H, Zhang J, Wang K. World J Surg Oncol; 2014 Dec 02; 12():367. PubMed ID: 25441176 [Abstract] [Full Text] [Related]
60. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I. Cancer Res; 2005 Jun 01; 65(11):4485-9. PubMed ID: 15930262 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]